SEC Comment Letter 0000000000-23-014094 to BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
Date: Dec. 26, 2023 · CIK: 0001580063 · Accession: 0000000000-23-014094
AI Filing Summary & Sentiment
File numbers found in text: 333-276260
Letter
United States securities and exchange commission logo December 26, 2023 Clarke Neumann, Esq. General Counsel Biora Therapeutics, Inc. 4330 La Jolla Village Drive, Suite 300 San Diego, CA 92122 Re:Biora Therapeutics, Inc. Registration Statement on Form S-3 Filed December 22, 2023 File No. 333-276260 Dear Clarke Neumann: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stewart L. McDowell, Esq.
Show Raw Text
United States securities and exchange commission logo
December 26, 2023
Clarke Neumann, Esq.
General Counsel
Biora Therapeutics, Inc.
4330 La Jolla Village Drive, Suite 300
San Diego, CA 92122
Re:Biora Therapeutics, Inc.
Registration Statement on Form S-3
Filed December 22, 2023
File No. 333-276260
Dear Clarke Neumann:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stewart L. McDowell, Esq.